X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs ASTRAZENECA PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD ASTRAZENECA PHARMA WYETH LTD/
ASTRAZENECA PHARMA
 
P/E (TTM) x 27.7 90.6 30.6% View Chart
P/BV x 5.3 12.9 41.4% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 WYETH LTD   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
ASTRAZENECA PHARMA
Mar-14
WYETH LTD/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0441,285 81.3%   
Low Rs818634 129.0%   
Sales per share (Unadj.) Rs298.6189.6 157.5%  
Earnings per share (Unadj.) Rs57.2-0.2 -28,114.1%  
Cash flow per share (Unadj.) Rs58.43.8 1,519.4%  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.568.6 363.4%  
Shares outstanding (eoy) m22.7225.00 90.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.15.1 61.6%   
Avg P/E ratio x16.3-4,712.7 -0.3%  
P/CF ratio (eoy) x15.9249.6 6.4%  
Price / Book Value ratio x3.714.0 26.7%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,15723,988 88.2%   
No. of employees `0000.51.6 31.6%   
Total wages/salary Rs m4001,605 24.9%   
Avg. sales/employee Rs Th13,787.43,040.2 453.5%   
Avg. wages/employee Rs Th813.01,029.2 79.0%   
Avg. net profit/employee Rs Th2,643.3-3.3 -80,960.6%   
INCOME DATA
Net Sales Rs m6,7834,740 143.1%  
Other income Rs m35392 382.8%   
Total revenues Rs m7,1364,832 147.7%   
Gross profit Rs m1,617-130 -1,246.0%  
Depreciation Rs m27101 26.3%   
Interest Rs m60-   
Profit before tax Rs m1,938-139 -1,395.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-5139 -3.7%   
Tax Rs m6325 12,420.4%   
Profit after tax Rs m1,301-5 -25,550.1%  
Gross profit margin %23.8-2.7 -870.6%  
Effective tax rate %32.6-3.7 -890.3%   
Net profit margin %19.2-0.1 -17,852.4%  
BALANCE SHEET DATA
Current assets Rs m6,9842,726 256.2%   
Current liabilities Rs m2,0562,435 84.4%   
Net working cap to sales %72.66.1 1,181.6%  
Current ratio x3.41.1 303.4%  
Inventory Days Days9974 134.6%  
Debtors Days Days2441 58.7%  
Net fixed assets Rs m2441,035 23.6%   
Share capital Rs m22750 454.4%   
"Free" reserves Rs m5,441942 577.3%   
Net worth Rs m5,6681,716 330.3%   
Long term debt Rs m250-   
Total assets Rs m7,9014,156 190.1%  
Interest coverage x353.3NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.91.1 75.3%   
Return on assets %16.5-0.1 -13,496.4%  
Return on equity %22.9-0.3 -7,735.4%  
Return on capital %34.00-  
Exports to sales %0.25.7 3.8%   
Imports to sales %36.36.5 562.4%   
Exports (fob) Rs m15270 5.5%   
Imports (cif) Rs m2,465306 804.9%   
Fx inflow Rs m15375 4.1%   
Fx outflow Rs m2,677470 569.4%   
Net fx Rs m-2,662-96 2,786.0%   
CASH FLOW
From Operations Rs m923-8 -11,397.5%  
From Investments Rs m317-146 -217.5%  
From Financial Activity Rs m-481862 -55.8%  
Net Cashflow Rs m759709 107.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 75.0 68.1%  
Indian inst/Mut Fund % 11.3 0.3 3,766.7%  
FIIs % 7.2 15.7 45.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 9.1 334.1%  
Shareholders   21,978 12,856 171.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   PLETHICO PHARMA  ELDER PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Higher; Pharma Stocks Among Top Gainers(01:30 pm)

After opening the day in green, share markets in India witnessed choppy trades and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS